tiprankstipranks
Trending News
More News >
Universal Health (UHS)
NYSE:UHS
US Market

Universal Health (UHS) Stock Forecast & Price Target

Compare
489 Followers
See the Price Targets and Ratings of:

UHS Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
5 Buy
7 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Universal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

$223.09
▲(17.98%Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $223.09 with a high forecast of $257.00 and a low forecast of $200.00. The average price target represents a 17.98% change from the last price of $189.09.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"173":"$173","258":"$258","194.25":"$194.3","215.5":"$215.5","236.75":"$236.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":257,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$257.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":223.09,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$223.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":200,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$200.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[173,194.25,215.5,236.75,258],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.38,192.73538461538462,198.09076923076924,203.44615384615383,208.80153846153846,214.15692307692308,219.5123076923077,224.86769230769232,230.22307692307692,235.57846153846154,240.93384615384616,246.28923076923076,251.6446153846154,{"y":257,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.38,190.12692307692308,192.87384615384616,195.6207692307692,198.3676923076923,201.11461538461538,203.86153846153846,206.60846153846154,209.35538461538462,212.1023076923077,214.84923076923076,217.59615384615384,220.34307692307692,{"y":223.09,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,187.38,188.35076923076923,189.32153846153847,190.2923076923077,191.2630769230769,192.23384615384614,193.20461538461538,194.17538461538462,195.14615384615385,196.1169230769231,197.0876923076923,198.05846153846153,199.02923076923076,{"y":200,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":188.84,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.47,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":237.01,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":223.94,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.61,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.42,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":179.03,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.87,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.61,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":187.38,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$257.00Average Price Target$223.09Lowest Price Target$200.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on UHS
TipRanks AITipRanks
Not Ranked
TipRanks
$208
Buy
10.00%
Upside
Reiterated
06/05/25
Universal Health Services demonstrates solid financial performance with consistent revenue growth and effective cash flow management. The attractive valuation suggests potential for appreciation, despite a modest dividend yield. Technical analysis indicates stable market sentiment, but caution is advised due to uncertainties in Medicaid payments and cash flow challenges. Overall, the company is well-positioned for future growth, supported by strong financials and strategic management.
Morgan Stanley Analyst forecast on UHS
Craig HettenbachMorgan Stanley
Morgan Stanley
$200
Hold
5.77%
Upside
Reiterated
06/04/25
Balanced Outlook for Universal Health Services Amid Valuation Opportunities and Market Caution
Leerink Partners Analyst forecast on UHS
Whit MayoLeerink Partners
Leerink Partners
$250$252
Buy
33.27%
Upside
Reiterated
06/04/25
Leerink Partners Sticks to Its Buy Rating for Universal Health (UHS)
Wells Fargo Analyst forecast on UHS
Stephen BaxterWells Fargo
Wells Fargo
$225
Buy
18.99%
Upside
Reiterated
05/29/25
Wells Fargo Keeps Their Buy Rating on Universal Health (UHS)
Cantor Fitzgerald Analyst forecast on UHS
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$227
Hold
20.05%
Upside
Reiterated
05/28/25
Cantor Fitzgerald Sticks to Its Hold Rating for Universal Health (UHS)
RBC Capital Analyst forecast on UHS
Ben HendrixRBC Capital
RBC Capital
$211$201
Hold
6.30%
Upside
Reiterated
04/30/25
Analysts Conflicted on These Healthcare Names: Universal Health (NYSE: UHS), SAGE Therapeutics (NASDAQ: SAGE) and Henry Schein (NASDAQ: HSIC)
KeyBanc
Hold
Reiterated
04/30/25
KeyBanc Remains a Hold on Universal Health (UHS)
Guggenheim Analyst forecast on UHS
Jason CassorlaGuggenheim
Guggenheim
$208$212
Buy
12.12%
Upside
Reiterated
04/30/25
Universal Health Services (UHS) PT Raised to $212 at GuggenheimGuggenheim analyst Jason Cassorla raised the price target on Universal Health Services (NYSE: UHS) to $212.00 (from $208.00) while maintaining a Buy rating.
Bank of America Securities Analyst forecast on UHS
Joanna GajukBank of America Securities
Bank of America Securities
$215
Hold
13.70%
Upside
Reiterated
04/29/25
Cautious Hold Rating on Universal Health Amid Mixed Segment Performance and Policy Risks
TD Cowen
$226
Buy
19.52%
Upside
Reiterated
04/29/25
TD Cowen Sticks to Their Buy Rating for Universal Health (UHS)
Barclays
$249$257
Buy
35.91%
Upside
Reiterated
04/29/25
Universal Health (UHS) Gets a Buy from Barclays
Robert W. Baird Analyst forecast on UHS
Michael HaRobert W. Baird
Robert W. Baird
$274$224
Hold
18.46%
Upside
Downgraded
04/14/25
Universal Health downgraded to Neutral from Outperform at BairdUniversal Health downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on UHS
Benjamin RossiJ.P. Morgan
J.P. Morgan
$215
Hold
13.70%
Upside
Reiterated
03/14/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molecular Partners (NASDAQ: MOLN), United Therapeutics (NASDAQ: UTHR) and Universal Health (NYSE: UHS)
UBS
$267
Buy
41.20%
Upside
Reiterated
02/27/25
UBS reiterates Buy Rating on Universal Health Services (UHS)UBS analyst AJ Rice reiterated a Buy rating and $267.00 price target on Universal Health Services (NYSE: UHS).
Stephens Analyst forecast on UHS
Scott FidelStephens
Stephens
$223
Hold
17.93%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: Vericel (NASDAQ: VCEL), Radnet (NASDAQ: RDNT) and Universal Health (NYSE: UHS)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on UHS
TipRanks AITipRanks
Not Ranked
TipRanks
$208
Buy
10.00%
Upside
Reiterated
06/05/25
Universal Health Services demonstrates solid financial performance with consistent revenue growth and effective cash flow management. The attractive valuation suggests potential for appreciation, despite a modest dividend yield. Technical analysis indicates stable market sentiment, but caution is advised due to uncertainties in Medicaid payments and cash flow challenges. Overall, the company is well-positioned for future growth, supported by strong financials and strategic management.
Morgan Stanley Analyst forecast on UHS
Craig HettenbachMorgan Stanley
Morgan Stanley
$200
Hold
5.77%
Upside
Reiterated
06/04/25
Balanced Outlook for Universal Health Services Amid Valuation Opportunities and Market Caution
Leerink Partners Analyst forecast on UHS
Whit MayoLeerink Partners
Leerink Partners
$250$252
Buy
33.27%
Upside
Reiterated
06/04/25
Leerink Partners Sticks to Its Buy Rating for Universal Health (UHS)
Wells Fargo Analyst forecast on UHS
Stephen BaxterWells Fargo
Wells Fargo
$225
Buy
18.99%
Upside
Reiterated
05/29/25
Wells Fargo Keeps Their Buy Rating on Universal Health (UHS)
Cantor Fitzgerald Analyst forecast on UHS
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$227
Hold
20.05%
Upside
Reiterated
05/28/25
Cantor Fitzgerald Sticks to Its Hold Rating for Universal Health (UHS)
RBC Capital Analyst forecast on UHS
Ben HendrixRBC Capital
RBC Capital
$211$201
Hold
6.30%
Upside
Reiterated
04/30/25
Analysts Conflicted on These Healthcare Names: Universal Health (NYSE: UHS), SAGE Therapeutics (NASDAQ: SAGE) and Henry Schein (NASDAQ: HSIC)
KeyBanc
Hold
Reiterated
04/30/25
KeyBanc Remains a Hold on Universal Health (UHS)
Guggenheim Analyst forecast on UHS
Jason CassorlaGuggenheim
Guggenheim
$208$212
Buy
12.12%
Upside
Reiterated
04/30/25
Universal Health Services (UHS) PT Raised to $212 at GuggenheimGuggenheim analyst Jason Cassorla raised the price target on Universal Health Services (NYSE: UHS) to $212.00 (from $208.00) while maintaining a Buy rating.
Bank of America Securities Analyst forecast on UHS
Joanna GajukBank of America Securities
Bank of America Securities
$215
Hold
13.70%
Upside
Reiterated
04/29/25
Cautious Hold Rating on Universal Health Amid Mixed Segment Performance and Policy Risks
TD Cowen
$226
Buy
19.52%
Upside
Reiterated
04/29/25
TD Cowen Sticks to Their Buy Rating for Universal Health (UHS)
Barclays
$249$257
Buy
35.91%
Upside
Reiterated
04/29/25
Universal Health (UHS) Gets a Buy from Barclays
Robert W. Baird Analyst forecast on UHS
Michael HaRobert W. Baird
Robert W. Baird
$274$224
Hold
18.46%
Upside
Downgraded
04/14/25
Universal Health downgraded to Neutral from Outperform at BairdUniversal Health downgraded to Neutral from Outperform at Baird
J.P. Morgan Analyst forecast on UHS
Benjamin RossiJ.P. Morgan
J.P. Morgan
$215
Hold
13.70%
Upside
Reiterated
03/14/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molecular Partners (NASDAQ: MOLN), United Therapeutics (NASDAQ: UTHR) and Universal Health (NYSE: UHS)
UBS
$267
Buy
41.20%
Upside
Reiterated
02/27/25
UBS reiterates Buy Rating on Universal Health Services (UHS)UBS analyst AJ Rice reiterated a Buy rating and $267.00 price target on Universal Health Services (NYSE: UHS).
Stephens Analyst forecast on UHS
Scott FidelStephens
Stephens
$223
Hold
17.93%
Upside
Reiterated
02/27/25
Analysts Offer Insights on Healthcare Companies: Vericel (NASDAQ: VCEL), Radnet (NASDAQ: RDNT) and Universal Health (NYSE: UHS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

1 Month
xxx
Success Rate
16/22 ratings generated profit
73%
Average Return
+1.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 72.73% of your transactions generating a profit, with an average return of +1.36% per trade.
3 Months
xxx
Success Rate
19/26 ratings generated profit
73%
Average Return
+3.80%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.08% of your transactions generating a profit, with an average return of +3.80% per trade.
1 Year
Whit MayoLeerink Partners
Success Rate
17/26 ratings generated profit
65%
Average Return
+6.67%
reiterated a buy rating 3 days ago
Copying Whit Mayo's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +6.67% per trade.
2 Years
xxx
Success Rate
20/26 ratings generated profit
77%
Average Return
+11.29%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +11.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
5
6
12
10
10
Hold
6
6
13
11
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
25
21
19
In the current month, UHS has received 10 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. UHS average Analyst price target in the past 3 months is 223.09.
Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is $4.98 with a range of $4.65 to $5.84. The previous quarter’s EPS was $4.84. UHS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year UHS has Outperformed its overall industry.
Next quarter’s earnings estimate for UHS is $4.98 with a range of $4.65 to $5.84. The previous quarter’s EPS was $4.84. UHS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year UHS has Outperformed its overall industry.

UHS Sales Forecast

Next quarter’s sales forecast for UHS is $4.24B with a range of $4.18B to $4.29B. The previous quarter’s sales results were $4.10B. UHS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year UHS has Outperformed its overall industry.
Next quarter’s sales forecast for UHS is $4.24B with a range of $4.18B to $4.29B. The previous quarter’s sales results were $4.10B. UHS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year UHS has Outperformed its overall industry.

UHS Stock Forecast FAQ

What is UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health’s 12-month average price target is 223.09.
    What is UHS’s upside potential, based on the analysts’ average price target?
    Universal Health has 17.98% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UHS a Buy, Sell or Hold?
          Universal Health has a consensus rating of Moderate Buy which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Universal Health’s price target?
            The average price target for Universal Health is 223.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $257.00 ,the lowest forecast is $200.00. The average price target represents 17.98% Increase from the current price of $189.09.
              What do analysts say about Universal Health?
              Universal Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of UHS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis